Associate Professor, Medicine, University of Washington School of Medicine
Hematology
Dr. Pamela S. Becker, MD
|
|
Give Review
Pamela S. Becker practices Hematology. She went to Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. Pamela Becker is also published. She has 24 publications published. The lastest publication: "Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.' Doctor Pamela S. Becker, MD accepts Medicare.
Publications
- Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with Acute myeloid leukaemia or high-risk MDS.
- Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: ...
- Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in Acute myeloid leukemia.
- Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact on Outcome in Acute Myeloid Leukemia.
- Sparse expression bases in cancer reveal tumor drivers.
- Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
- Idarubicin, cytarabine, and pravastatin as induction therapy for untreated Acute myeloid leukemia and high-risk myelodysplastic syndrome.
- Correlation between peripheral blood and bone marrow regarding FLT3-ITD and NPM1 mutational status in patients with Acute myeloid leukemia.
- G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of Acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloprolif...
- Panobinostat: a review of trial results and future prospects in multiple Myeloma.
- Optimizing stem Cell mobilization: lessons learned.
- Value of Routine 'Day 14' Marrow Exam in Newly-Diagnosed AML.
- Management of Acute Myeloid Leukemia in the Intensive Care Setting.
- Lenalidomide Maintenance for High-Risk Multiple Myeloma after Allogeneic Hematopoietic Cell Transplantation.
- A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple Myeloma.
- The NCI common toxicity criteria and treatment-associated mortality in Acute myeloid leukemia.
- A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed Acute myeloid leukaemia.
- The proportion of CD34(+)CD38(low or neg) myeloblasts, but not side population frequency, predicts initial response to induction therapy in patients with newly diagnos...
- Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage th...
- Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi Anemia without causing cytogenetic abnormalities.
- A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myel...
- Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with Acute myeloid leukemia.
- Evaluation of early discharge after hospital treatment of neutropenic fever in Acute myeloid leukemia (AML).
Schools
Harvard Medical School
Beth Israel Hospital
Yale University School Of Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Beth Israel Deaconess Medical Center -
Harvard Medical School
Hospital
-
Seattle Children's Hospital -
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1861578668 | |
| NPPES Provider LastName | BECKER | |
| NPPES Provider FirstName | PAMELA | |
| NPPES Provider ZIPCode | 98109 | |
| NPPES Provider State | WA | |
| Specialty Description | Hematology | |
| Total Claim Count | 398.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861578668 |
| Last Name Of The Provider | BECKER |
| First Name Of The Provider | PAMELA |
| View All |
Similar Doctors
|
|
Dr. Prakash Vishnu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David White, MD |
|
|
Dr. Todd S. Barry, MD |
|
|
Dr. Sindhu Cherian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harvey A. Greisman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lorinda A. Soma, MD |
|
|
Dr. Barbara A. Konkle, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Kelly M. Smith, MD |
|
|
Dr. Terry B. Gernsheimer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rui F. Bergantim, MD |
|
|
Dr. Gregory J. Delzoppo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aude Chapuis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria T. Zudaire, MD |
|
|
Dr. Roland B. Walter, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Kristina E. Sohlbach |